ArticleFrontiers in oncology2022

Survival Is Worse in Patients Completing Immunotherapy Prior to SBRT/SRS Compared to Those Receiving It Concurrently or After.

Susan Woody et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.